Air pollution can contribute to obesity and diabetes, suggests study Dr. Kamal Kant Kohli21 Nov 2025 8:45 PM ISTThere is growing evidence that air pollution is not just harmful to our lungs and heart, but also plays a significant role in the development of...
Medical Bulletin 21/November/2025 Anshika Mishra21 Nov 2025 3:00 PM ISTHere are the top medical news for the day:ICMR reports that 56% of chronic diseases in India are linked to unhealthy diets and poor lifestyle choices ...
ICMR reports that 56 percent of chronic diseases in India are linked to unhealthy diets and poor lifestyle choices Anshika Mishra21 Nov 2025 8:00 AM ISTThe Indian Council of Medical Research (ICMR) has unveiled a startling fact: 56.4% of India's total disease burden stems from unhealthy diets,...
Tirzepatide Shows No Increased Heart Failure Risk in Meta-Analysis Dr Riya Dave20 Nov 2025 9:15 PM ISTA review and meta-analysis published in Diabetes Metabolism Research and Reviews has revealed that tirzepatide has a neutral effect on heart failure...
Albuminuria in Type 2 Diabetes and Risk of Cardiorenal Outcomes- Insights from Latest JACC Advances Study Including >74,000 Patients Dr. Bhumika Maikhuri20 Nov 2025 11:45 AM ISTA recent study has found that 40% of patients with type 2 diabetes (T2D) have albuminuria and may benefit from cardiovascular and renoprotective...
Study reveals strong link between type 2 diabetes and hearing loss Dr. Kamal Kant Kohli19 Nov 2025 9:30 PM ISTAs the United States observes American Diabetes Month this November, a comprehensive study published in Otolaryngology-Head and Neck Surgery, the...
Sotagliflozin outperforms dapagliflozin for reducing salt- sensitive hypertension and kidney injury: Study Dr. Kamal Kant Kohli18 Nov 2025 8:45 PM ISTSodium-glucose co-transporter 2 (SGLT2) inhibitors, initially developed to treat type 2 diabetes, have significant heart- and kidney- protective...
Tirzepatide Linked to Higher Risk of Osteoporosis and Fracture compared to other GLP-1 receptor agonists: Study Dr Riya Dave18 Nov 2025 8:30 PM ISTResearchers have found in a new large real-world cohort study that starting tirzepatide was associated with a significantly increased risk of...
Semaglutide, tirzepatide, and dulaglutide have similar Gl safety profiles in clinical settings, suggests study Dr. Kamal Kant Kohli18 Nov 2025 9:15 AM ISTA new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients...
Time of eating changes lipid profile during intermittent fasting: Study Dr. Kamal Kant Kohli17 Nov 2025 8:00 AM ISTThe time of eating influences the lipid metabolism in our body. A study conducted at the German Center for Diabetes Research (DZD) and the German...
Obesity drugs improve heart health: Study shows additional benefits of semaglutide and tirzepatide Dr. Kamal Kant Kohli13 Nov 2025 8:15 PM ISTInjectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical...
Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman Deeksha Bhandari13 Nov 2025 6:00 PM ISTOn this World Diabetes Day, we bring you a special episode of Dia Dialogues titled "Gliclazide - Revisiting a Preferred Sulphonylurea in 2025." ...
